A detailed history of Banque Transatlantique Sa transactions in Amgen Inc stock. As of the latest transaction made, Banque Transatlantique Sa holds 143,292 shares of AMGN stock, worth $40.8 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
143,292
Previous 1,712 8269.86%
Holding current value
$40.8 Million
Previous $445 Million 89.97%
% of portfolio
0.79%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$258.59 - $327.36 $36.6 Million - $46.3 Million
141,580 Added 8269.86%
143,292 $44.6 Million
Q4 2024

Feb 14, 2025

BUY
$258.78 - $328.31 $443,031 - $562,066
1,712 New
1,712 $445 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Banque Transatlantique Sa Portfolio

Follow Banque Transatlantique Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Transatlantique Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Transatlantique Sa with notifications on news.